Vous êtes ici

2018

2018

1-  Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018;90(21):e1858-e1869. IF 2018 = 8.689; 5YIF = 9.025

2- Brun S, Schall N, Bonam SR, Bigaut K, Mensah-Nyagan AG, de Sèze J, Muller S. An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies. J Autoimmun. 2018;92:114-125. doi: 10.1016/j.jaut.2018.05.009. IF 2018 = 7.543; 5YIF = 7.228

3- Klein C, Roussel G, Brun S, Rusu C, Patte-Mensah C, Maitre M, Mensah-Nyagan AG. 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease. Acta Neuropathol Commun. 2018; doi: 10.1186/s40478-018-0640-z. IF 2018 = 5.883; 5YIF = 5.860

4-  Bund C, Lhermitte B, De Seze J, Kremer S, Namer IJ. FDG PET and MRI Findings in a Case of Bing-Neel Syndrome. Clin Nucl Med. 2018;43(4):262-264. doi: 10.1097/RLU.0000000000002019. IF 2018 = 6.703; 5YIF = 5.079

5-  Jeanjean M, Bind MA, Roux J, Ongagna JC, de Sèze J, Bard D, Leray E. Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses. Environ Res. 2018;163:43-52. doi: 10.1016/j.envres.2018.01.040. IF 2018 = 5.026; 5YIF = 5.051

6-  Cès A, Burg T, Herbeaux K, Héraud C, Bott JB, Mensah-Nyagan AG, Mathis C. Age-related vulnerability of pattern separation in C57BL/6J mice. Neurobiol Aging. 2018;62:120-129. doi: 10.1016/j.neurobiolaging.2017.10.013. IF 2018 = 4.398; 5YIF = 4.905

7-  Corti L, Ayrignac X, Carra Dalliere C, Charif M, de Sèze J, Biotti D, Ciron J, Labauge P. Late activity rebound in non-active multiple sclerosis: A rare event. Mult Scler J. 2018;1352458518765670. doi: 10.1177/1352458518765670. IF 2018 = 5.649; 5YIF = 4.862

8-  Combès B, Kerbrat A, Ferré JC, Callot V, Maranzano J, Badji A, Le Page E, Labauge P, Ayrignac X, Carra Dallière C, de Champfleur NM, Pelletier J, Maarouf A, de Seze J, Collongues N, Brassat D, Durand-Dubief F, Barillot C, Bannier E, Edan G; EMISEP Study Group. Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study. Mult Scler J. 2018;1352458518781999. doi: 10.1177/1352458518781999. IF 2017 = 5,280; 5YIF = 4.741

9-  Tourbah A, Gout O, Vighetto A, Deburghgraeve V, Pelletier J, Papeix C, Lebrun-Frenay C, Labauge P, Brassat D, Toosy A, Laplaud DA, Outteryck O, Moreau T, Debouverie M, Clavelou P, Heinzlef O, De Sèze J, Defer G, Sedel F, Arndt C. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. CNS Drugs. 2018;32(7):661-672. doi: 10.1007/s40263-018-0528-2. IF 2018 = 4.192; 5YIF = 4.629

10- Cabre P, Mejdoubi M, Jeannin S, Merle H, Plumelle Y, Cavillon G, Smadja D, Marignier R; Francophone Society of Multiple Sclerosis and OFSEP investigators. Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study. J Neurol. 2018;265(4):917-925. doi: 10.1007/s00415-018-8771-5. IF 2018 = 4.204; 5YIF = 3.999

11- Fitsiori A, Fornecker LM, Simon L, Karentzos A, Galanaud D, Outteryck O, Vermersch P, Pruvo JP, Gerardin E, Lebrun-Frenay C, Lafitte F, Cottier JP, Clerc C, de Seze J, Dietemann JL, Kremer S. Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia? Eur Radiol. 2018; doi: 10.1007/s00330-018-5543-7. IF 2018 = 3.962; 5YIF = 3.919

12 Wilding AS, Patte-Mensah C, Taleb O, Brun S, Kemmel V, Mensah-Nyagan AG. Protective effect of 4-Phenylbutyrate against proteolipid protein mutation-induced endoplasmic reticulum stress and oligodendroglial cell death. Neurochem Int. 2018;118:185-194. doi: 10.1016/j.neuint.2018.06.008. IF 2018 = 3.994; 5YIF = 3.867

13- Kuchler-Bopp S, Bagnard D, Van-Der-Heyden M, Idoux-Gillet Y, Strub M, Gegout H, Lesot H, Benkirane-Jessel N, Keller L. Semaphorin 3A receptor inhibitor as a novel therapeutic to promote innervation of bioengineered teeth. J Tissue Eng Regen Med. 2018;12(4):e2151-e2161. doi: 10.1002/term.2648. IF 2018 = 3.319; 5YIF = 3.435

14 Collongues N, Samama B, Schmidt-Mutter C, Chamard-Witkowski L, Debouverie M, Chanson JB, Antal MC, Benardais K, de Seze J, Velten M, Boehm N. Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy. PLoS One. 2018;13(1):e0191614. doi: 10.1371/journal.pone.0191614. eCollection 2018. IF 2018 = 2.776; 5YIF = 3.337

15- Patte-Mensah C, Meyer L, Kemmel V, Geoffroy P, Miesch M, Mensah-Nyagan AG. Evidence for effective structure-based neuromodulatory effects of new analogues of neurosteroid allopregnanolone. J Neuroendocrinol. 2018;30(2). doi: 10.1111/jne.12568. IF 2018 = 3.040; 5YIF = 3.287

16- Bezine M, Namsi A, Sghaier R, Ben Khalifa R, Hamdouni H, Brahmi F, Badreddine I, Mihoubi W, Nury T, Vejux A, Zarrouk A, de Sèze J, Moreau T, Nasser B, Lizard G. The effect of oxysterols on nerve impulses. Biochimie. 2018;153:46-51. doi: 10.1016/j.biochi.2018.04.013. Review. IF 2018 = 3.362;  5YIF = 3.230

17- Bezine M, Maatoug S, Ben Khalifa R, Debbabi M, Zarrouk A, Wang Y, Griffiths WJ, Nury T, Samadi M, Vejux A, de Sèze J, Moreau T, Kharrat R, El Ayeb M, Lizard G. Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0). Biochimie. 2018;153:56-69. doi: 10.1016/j.biochi.2018.02.008. IF 2018 = 3.362;  5YIF = 3.230

18- Collongues N, Patte-Mensah C, De Seze J, Mensah-Nyagan AG, Derfuss T. Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics. Expert Rev Neurother. 2018;18(6):515-522. doi: 10.1080/14737175.2018.1481390. IF 2018 = 3.453; 5YIF = 3.144

19- Vitet L, Patte-Mensah C, Boujedaini N, Mensah-Nyagan AG, Meyer L. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms. Neurol Sci. 2018;doi: 10.1007/s10072-018-3575-z. IF 2018 = 2.484; 5YIF = 2.227